“1 year subscription print edition of the Belgian Journal of Hematology (BJH)” has been added to your cart. View cart

Article: JAK2 inhibitor pacritinib significantly benefits patient reported outcomes in myelofibrosis

€2.42

SKU: product-article-18806 Category: General

Description

Description

JAK2 inhibitor pacritinib significantly benefits patient reported outcomes in myelofibrosis

Top

Article: JAK2 inhibitor pacritinib significantly benefits patient reported outcomes in myelofibrosis

Description

Related products

Article: INTRODUCTION

Article: Highlights in genitourinary cancers

1 year access Online Belgian Journal of Hematology (BJH)

1 year subscription print edition of the Belgian Journal of Hematology (BJH)